PortfoliosLab logo

UroGen Pharma Ltd. (URGN)

Equity · Currency in USD · Last updated May 21, 2022

Company Info

Trading Data

  • Previous Close$5.61
  • Year Range$5.51 - $19.13
  • EMA (50)$7.11
  • EMA (200)$10.87
  • Average Volume$151.33K
  • Market Capitalization$127.31M

URGNShare Price Chart


Chart placeholderClick Calculate to get results

URGNPerformance

The chart shows the growth of $10,000 invested in UroGen Pharma Ltd. on May 4, 2017 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $4,315 for a total return of roughly -56.85%. All prices are adjusted for splits and dividends.


URGN (UroGen Pharma Ltd.)
Benchmark (^GSPC)

URGNReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-23.67%-12.57%
YTD-41.01%-18.14%
6M-55.19%-17.07%
1Y-69.23%-5.21%
5Y-21.53%10.37%
10Y-15.34%10.21%

URGNMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

URGNSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current UroGen Pharma Ltd. Sharpe ratio is -1.06. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


URGN (UroGen Pharma Ltd.)
Benchmark (^GSPC)

URGNDividend History


UroGen Pharma Ltd. doesn't pay dividends

URGNDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


URGN (UroGen Pharma Ltd.)
Benchmark (^GSPC)

URGNWorst Drawdowns

The table below shows the maximum drawdowns of the UroGen Pharma Ltd.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the UroGen Pharma Ltd. is 91.57%, recorded on May 19, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.57%May 21, 20181008May 19, 2022
-20.07%May 31, 201712Jun 15, 20177Jun 26, 201719
-18.48%Jan 26, 20187Feb 5, 201819Mar 5, 201826
-16.63%Sep 15, 201726Oct 20, 20179Nov 2, 201735
-15.97%Mar 15, 201812Apr 2, 20181Apr 3, 201813
-14.93%Nov 14, 201721Dec 13, 201713Jan 3, 201834
-13.38%Jun 28, 201738Aug 21, 20177Aug 30, 201745
-11.4%Apr 5, 201818Apr 30, 201814May 18, 201832
-5.75%Jan 17, 20182Jan 18, 20182Jan 22, 20184
-4.09%May 17, 20171May 17, 20171May 18, 20172

URGNVolatility Chart

Current UroGen Pharma Ltd. volatility is 85.74%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


URGN (UroGen Pharma Ltd.)
Benchmark (^GSPC)

Portfolios with UroGen Pharma Ltd.


Loading data...

More Tools for UroGen Pharma Ltd.